XL-PROTEIN GMBH
XL-protein is a biopharmaceutical company utilizing its proprietary ‘PASylation’ technology to develop second generation biopharmaceuticals with prolonged plasma half-life. PASylation of therapeutic proteins allows less frequent and lower dosing combined with better tolerability, also opening perspectives for follow-on products of approved biopharmaceuticals. ‘PASylation’ – the genetic fusion with conformationally disordered polypeptide sequences composed of the amino acids Pro, ... Ala, and Ser – provides a superior way to attach a solvated random chain with large hydrodynamic volume to a biologically active protein. Thus, its typically rapid clearance via kidney filtration can be retarded by one to two orders of magnitude while the PAS moiety is biochemically inert and easily degradable.
XL-PROTEIN GMBH
Industry:
Biotechnology
Founded:
2009-01-01
Address:
Freising, Bayern, Germany
Country:
Germany
Website Url:
http://www.xl-protein.com
Total Employee:
1+
Status:
Active
Contact:
+49 (0) 8161 53730-90
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Tag Manager WordPress Sitelinks Search Box Euro Amazon Yoast WordPress SEO Plugin Yoast SEO Premium
Current Employees Featured
Founder
Official Site Inspections
http://www.xl-protein.com
- Host name: web47.alfahosting-server.de
- IP address: 5.44.111.22
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "XL-protein GmbH"
Corporate overview - XL-protein offers PASylation, a biological ...
XL-protein is a privatly owned German biotech company commercializing the revolutionary PASylation technology, which enables the design of biopharmaceuticals with extended plasma …See details»
Homepage - XL-protein offers PASylation, a biological alternative …
About XL-protein XL-protein (www.xl-protein.com) is a German biotech company commercializing its ground-breaking PASylation ® technology, which enables the design of biopharmaceuticals …See details»
XL-protein GmbH - Crunchbase Company Profile & Funding
XL-protein is a biopharmaceutical company utilizing its proprietary ‘PASylation’ technology to develop second generation biopharmaceuticals. with prolonged plasma half-life. PASylation of …See details»
XL-protein Company Profile - Office Locations, Competitors ... - Craft
XL-protein is a company that develops and commercializes its proprietary PASylation technology to extend the plasma half-life of biopharmaceuticals. It provides a way to attach a solvated …See details»
XL-protein - VentureRadar
XL-protein is a German biotech company commercializing its ground-breaking PASylation®technology, which enables the design of biopharmaceuticals with extended …See details»
XL-protein GmbH - Innovations- und Gründerzentrum …
XL-protein is a biopharmaceutical company utilizing its proprietary ‘PASylation’ technology to develop second generation biopharmaceuticals with prolonged plasma half-life. PASylation of therapeutic proteins allows less frequent and …See details»
XL-protein GmbH - Drug pipelines, Patents, Clinical trials - Synapse
Explore XL-protein GmbH with its drug pipeline, therapeutic area, technology platform, 1 news, and 24 literature, Disease Domain:Immune System Diseases, Infectious Diseases, …See details»
XL-protein (XL-protein GmbH) - Startbase
Jobs at XL-protein: Other Startups nearby. Gesellschaft für Informationsmanagement in der Biotechnologie - gimbio. Startup 2010 Freising. Gesellschaft für Informationsmanagement in der Biotechnologie - gimbio. …See details»
XL-protein GmbH (XL-protein GmbH) - 药物管线_专利_临床试验_ …
了解XL-protein GmbH (XL-protein GmbH)公司的药物管线，治疗领域，技术平台，以及它的1篇新闻和24篇文献，疾病领域:免疫系统疾病，感染，肿瘤，内分泌与代谢疾病，技术平台:合成多 …See details»
XL-protein - Products, Competitors, Financials, Employees, …
XL-protein specializes in the development and commercialization of PASylation technology, which is utilized to enhance the properties of biopharmaceuticals within the biopharmaceutical …See details»
XL-protein Corporate Headquarters, Office Locations and ... - Craft
XL-protein Headquarters and Office Locations. Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit. Button CTA. XL-protein is headquartered in Freising, Lise-Meitner …See details»
XL-protein - Overview, News & Similar companies | ZoomInfo.com
Jul 26, 2017 Ajinomoto and XL-protein Forge Strategic Alliance to Develop PASylated Therapeutics Applying the Corynex® Platform SAN DIEGO and FREISING, Germany, Dec. …See details»
XL-protein (XL-protein GmbH) - Startbase
Offene Jobs bei XL-protein: Weitere Startups in der Nähe von XL-protein. Gesellschaft für Informationsmanagement in der Biotechnologie - gimbio. Startup 2010 Freising. Gesellschaft …See details»
xl-250 - Drug Targets, Indications, Patents - Synapse - Patsnap
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.See details»
PASylated granulocyte macrophage colony stimulating factor - XL …
XL-protein GmbH is developing xl 150, PASylated granulocyte macrophage colony stimulating factor, for the treatment of cancer. The company is using its ... If your organization has a …See details»
News Archives - XL-protein offers PASylation, a biological …
Sep 28, 2022 About XL-protein XL-protein (www.xl-protein.com) is a German biotech company commercializing its ground-breaking PASylation ® technology, which enables the design of …See details»
XL-protein CEO and Key Executive Team | Craft.co
XL-protein's CEO, Managing Director, Founder is Claus Schalper. Claus Schalper. CEO, Managing Director, Founder. Source: xl-protein.com. Report incorrect company information. …See details»
Ajinomoto and XL-protein forge Strategic Alliance to develop …
SAN DIEGO, U.S.A., and FREISING, Germany, 18th December, 2018: Ajinomoto Bio-Pharma Services, a fully owned subsidiary of Ajinomoto Co. Inc. (TSE: 2802), and XL-protein GmbH, a …See details»
Leadership team - XL-protein offers PASylation, a biological ...
A Biochemist by training, she has spent over 15 years in drug discovery and development, with a focus on protein chemistry & protein design. Before joining XL-protein in 2014, Michaela was a …See details»
A tissue-specific atlas of protein–protein associations enables ...
1 day ago Despite progress in mapping protein–protein interactions, their tissue specificity is understudied. Here, given that protein coabundance is predictive of functional association, we …See details»